- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15.04. | After delay, first CDC vaccine panel under RFK Jr. meets to hash out recommendations | ||
| 15.04. | Sanofi signs up Chrissy Teigen for diabetes screening campaign | ||
| 15.04. | Trump administration launches national security investigation into pharmaceuticals, paving way for tariffs | ||
| 14.04. | Amgen bumps up pay for longtime CEO Robert Bradway 8% to $24.4M | ||
| 14.04. | Aurobindo gets Form 483 scolding from FDA at North Carolina inhaler plant | ||
| 14.04. | RFK Jr. blasts FDA as industry's 'sock puppet,' warns about 'deep state' influence at agency: Politico | ||
| 14.04. | Sandoz takes Amgen to court again, challenging its patents on decades-old Enbrel | ||
| 14.04. | In short reprieve for pharma, commerce secretary says drug tariffs to come 'in the next month or two' | ||
| 14.04. | 'Saturday Night Live' skewers drug ad tropes in Jon Hamm-led skit | ||
| 14.04. | Gilead reprimanded after PMCPA finds conference Wi-Fi sponsorship broke advertising rules | ||
| 14.04. | Theratechnologies juggles multiple suitors, including $255M offer from CDMO Future Pak | ||
| 11.04. | Navigating Retail and Specialty Lite Success: How Your Pharmacy Strategy Impacts Brand Performance | ||
| 11.04. | Amgen pads Imdelltra's case in tough-to-treat lung cancer subtype with phase 3 survival win | ||
| 11.04. | Bristol Myers combo follows Roche, AstraZeneca immunotherapy rivals into first-line liver cancer | ||
| 11.04. | After Hetlioz's rejection in jet lag disorder, Vanda sues FDA for right to promote off-label use | ||
| 11.04. | RFK Jr. looks to find cause of 'autism epidemic' by September through massive HHS research push | ||
| 11.04. | Argenx stays on a roll with Vyvgart, gaining FDA nod for at-home prefilled syringe | ||
| 11.04. | As Pfizer backs out of hemophilia gene therapy space, CSL hopes Hemgenix is here to stay | ||
| 11.04. | Fierce Pharma Asia-Congress' US-China biotech report; NIH's database ban; GSK's ABL neuroscience deal | ||
| 11.04. | As work on massive US plant continues, Kyowa Kirin wraps up construction of $118M biologics plant in Japan | ||
| 10.04. | Following pledges from Lilly and J&J, Novartis unveils $23B US investment to beef up manufacturing, R&D | ||
| 10.04. | Alzheimer's Association expands PSA campaign about early dementia signs to focus on Black Americans | ||
| 10.04. | Merck granted Rob Davis a pay boost to $23.2M, inching CEO's 2024 compensation closer to large pharma peers | ||
| 10.04. | Sun Pharma snags appeals win over Incyte, clearing way for US launch of alopecia med Leqselvi | ||
| 10.04. | Few psych drugs from past decade are on HCPs' radars: survey |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
